United States· US:50090-2980_db61f577-1818-4643-8712-23db5c162ae6
Atovaquone and Proguanil HCl
A proguanil and atovaquone product containing atovaquone; proguanil hydrochloride, registered in United States by A-S Medication Solutions. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Proguanil and atovaquone is registered in 13 of 19 countries.
Countries holding a registration under ATC P01BB51 (proguanil and atovaquone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Proguanil and atovaquone · ATC P01BB51
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of proguanil and atovaquone costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Proguanil and atovaquone · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.96
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ATOVAQUONE; PROGUANIL HYDROCHLORIDE
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- P01BB51
- ATC class
- Proguanil and atovaquone
- Defined daily dose
- 0.4 g, Proguanilhydroch
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 20
- ndc1150090298007 TABLET, FILM COATED in 1 BOTTLE (50090-2980-0)
- ndc11500902980112 TABLET, FILM COATED in 1 BOTTLE (50090-2980-1)
- ndc11500902980214 TABLET, FILM COATED in 1 BOTTLE (50090-2980-2)
- ndc11500902980316 TABLET, FILM COATED in 1 BOTTLE (50090-2980-3)
- ndc11500902980424 TABLET, FILM COATED in 1 BOTTLE (50090-2980-4)
- ndc1150090298055 TABLET, FILM COATED in 1 BOTTLE (50090-2980-5)
- ndc11500902980610 TABLET, FILM COATED in 1 BOTTLE (50090-2980-6)
- ndc115009029807100 TABLET, FILM COATED in 1 BOTTLE (50090-2980-7)
- ndc11500902980820 TABLET, FILM COATED in 1 BOTTLE (50090-2980-8)
- ndc11500902980930 TABLET, FILM COATED in 1 BOTTLE (50090-2980-9)
- ndc1150090-2980-0
- ndc1150090-2980-1
- ndc1150090-2980-2
- ndc1150090-2980-3
- ndc1150090-2980-4
- ndc1150090-2980-5
- ndc1150090-2980-6
- ndc1150090-2980-7
- ndc1150090-2980-8
- ndc1150090-2980-9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for proguanil and atovaquone.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Proguanil and atovaquone · interactions on record
40 records
- 4 severe
- 27 moderate
- 3 minor
Most severe, free to view
- EfavirenzJ05AG03severe
- Sodium aurothiomalateM01CB01severe
- AuranofinM01CB03severe
- AurothioglucoseM01CB04severe
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Proguanil and atovaquone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandFalcimarGlenmark Pharmaceuticals s.r.o.
- CzechiaMALARONEGlaxoSmithKline, S.A., Tres Cantos
- United KingdomMafamoz 250mg/100mg tabletsTeva UK Ltd
- FranceATOVAQUONE/PROGUANIL BGR 250 mg/100 mg, comprimé pelliculéBIOGARAN
- NetherlandsAtovaquon/Proguanil HCl Amarox 250/100 mg, filmomhulde tablettenAmarox Pharma B.V.
- GermanyAtovaquon/Proguanilhydrochlorid AlAliud Pharma Gmbh
- FinlandAtovaquone/Proguanil Ratiopharmratiopharm GmbH
- SwitzerlandAtovaquon Plus Spirig HC
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Atovaquon/Proguanilhydrochlorid Glenmark, Atovaquon/Proguanilhydrochlorid Stada
- Belgium · Atovaquone/Proguanil Eg, Atovaquone/Proguanil Viatris
- Czechia · Malarone
- Germany · Atovaquon/Proguanilhydrochlorid Al, Atovaquon/Proguanilhydrochlorid Amarox
- Denmark · Atovaquon/Proguanilhydrochlorid Glenmark, Malarone
- Estonia · Malarone, Malarone Paediatric
- Spain · Atovacuona/Hidrocloruro De Proguanil Viatris, Malarone
- Finland · Malarone
- France · Atovaquone/Proguanil Bgr, Atovaquone/Proguanil Biogaran
- United Kingdom (Northern Ireland) · Atovaquone/Proguanil Hydrochloride Amarox, Atovaquone/Proguanil Hydrochloride Glenmark Pharmaceuticals Eurpoe
- Greece · Malarone
- Hungary · Malarone
- Ireland · Atovaquone/Proguanil Hydrochloride Glenmark Arzneimittel, Atovaquone/Proguanil Hydrochloride Viatris
- Iceland · Malarone, Malastad
- Italy · Atovaquone E Proguanile Mylan Generics, Malarone
- Lithuania · Malarone
- Luxembourg · Atovaquon/Proguanilhydrochlorid Ratiopharm, Atovaquone/Proguanil Eg
- Latvia · Malarone
- Malta · Atovaquone/Proguanil Hydrochloride Amarox, Malarone
- Netherlands · Atovaquon/Proguanil Hcl Amarox, Atovaquon/Proguanil Hcl Cf
- Norway · Atovakon/Proguanil Glenmark, Malarone
- Poland · Falcimar, Malarone
- Portugal · Malarone
- Sweden · Atovaquone / Proguanil Glenmark, Malarone Junior
- Slovenia · Malarone
- Slovakia · Malarone
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a65d9b56-1866-4fc3-9e5c-822633eddb6c GET /v1/drugs/a65d9b56-1866-4fc3-9e5c-822633eddb6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250; 100",
"substance": "ATOVAQUONE; PROGUANIL HYDROCHLORIDE",
"productndc": "50090-2980",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA021078",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about proguanil and atovaquone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.